Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.

Li L, Meng W, Horton M, DiStefano DR, Thoryk EA, Pfaff JM, Wang Q, Salazar GT, Barnes T, Doranz BJ, Bett AJ, Casimiro DR, Vora KA, An Z, Zhang N.

PLoS Pathog. 2019 Jun 6;15(6):e1007716. doi: 10.1371/journal.ppat.1007716. eCollection 2019 Jun.

2.

SELfies and CELLfies: Whole Genome Sequencing and Annotation of Five Antibiotic Resistant Bacteria Isolated from the Surfaces of Smartphones, An Inquiry Based Laboratory Exercise in a Genomics Undergraduate Course at the Rochester Institute of Technology.

Parthasarathy A, Wong NH, Weiss AN, Tian S, Ali SE, Cavanaugh NT, Chinsky TM, Cramer CE, Gupta A, Jha R, Johnson LK, Tuason ED, Klafehn LM, Krishnadas V, Musich RJ, Pfaff JM, Richman SC, Shumway AJ, Hudson AO.

J Genomics. 2019 Feb 19;7:26-30. doi: 10.7150/jgen.31911. eCollection 2019.

3.

Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.

Gopal R, Jackson K, Tzarum N, Kong L, Ettenger A, Guest J, Pfaff JM, Barnes T, Honda A, Giang E, Davidson E, Wilson IA, Doranz BJ, Law M.

PLoS Pathog. 2017 Dec 18;13(12):e1006735. doi: 10.1371/journal.ppat.1006735. eCollection 2017 Dec.

4.

Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.

Bailey JR, Flyak AI, Cohen VJ, Li H, Wasilewski LN, Snider AE, Wang S, Learn GH, Kose N, Loerinc L, Lampley R, Cox AL, Pfaff JM, Doranz BJ, Shaw GM, Ray SC, Crowe JE Jr.

JCI Insight. 2017 May 4;2(9). pii: 92872. doi: 10.1172/jci.insight.92872. eCollection 2017 May 4.

5.

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.

Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE Jr, de Silva AM.

J Virol. 2017 Feb 14;91(5). pii: e02041-16. doi: 10.1128/JVI.02041-16. Print 2017 Mar 1.

6.

Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.

Xu M, Züst R, Toh YX, Pfaff JM, Kahle KM, Davidson E, Doranz BJ, Velumani S, Tukijan F, Wang CI, Fink K.

J Virol. 2016 Nov 28;90(24):11122-11131. Print 2016 Dec 15.

7.

Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.

Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE Jr, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS.

J Virol. 2016 Apr 29;90(10):5090-5097. doi: 10.1128/JVI.00155-16. Print 2016 May 15.

8.

Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.

Godoy-Lozano EE, Téllez-Sosa J, Sánchez-González G, Sámano-Sánchez H, Aguilar-Salgado A, Salinas-Rodríguez A, Cortina-Ceballos B, Vivanco-Cid H, Hernández-Flores K, Pfaff JM, Kahle KM, Doranz BJ, Gómez-Barreto RE, Valdovinos-Torres H, López-Martínez I, Rodriguez MH, Martínez-Barnetche J.

Genome Med. 2016 Feb 25;8(1):23. doi: 10.1186/s13073-016-0276-1.

9.

Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.

Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE Jr.

J Virol. 2015 Oct 28;90(2):780-9. doi: 10.1128/JVI.01805-15. Print 2016 Jan 15.

10.

Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

Davidson E, Bryan C, Fong RH, Barnes T, Pfaff JM, Mabila M, Rucker JB, Doranz BJ.

J Virol. 2015 Nov;89(21):10982-92. doi: 10.1128/JVI.01490-15. Epub 2015 Aug 26.

11.

Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.

Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE Jr, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1939-44. doi: 10.1073/pnas.1317350111. Epub 2014 Jan 2. Erratum in: Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):6115. Retraction in: Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2738.

12.

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.

Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE Jr.

MBio. 2013 Nov 19;4(6):e00873-13. doi: 10.1128/mBio.00873-13.

13.

Atomic-level functional model of dengue virus Envelope protein infectivity.

Christian EA, Kahle KM, Mattia K, Puffer BA, Pfaff JM, Miller A, Paes C, Davidson E, Doranz BJ.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18662-7. doi: 10.1073/pnas.1310962110. Epub 2013 Oct 24.

14.

Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.

Parrish NF, Wilen CB, Banks LB, Iyer SS, Pfaff JM, Salazar-Gonzalez JF, Salazar MG, Decker JM, Parrish EH, Berg A, Hopper J, Hora B, Kumar A, Mahlokozera T, Yuan S, Coleman C, Vermeulen M, Ding H, Ochsenbauer C, Tilton JC, Permar SR, Kappes JC, Betts MR, Busch MP, Gao F, Montefiori D, Haynes BF, Shaw GM, Hahn BH, Doms RW.

PLoS Pathog. 2012;8(5):e1002686. doi: 10.1371/journal.ppat.1002686. Epub 2012 May 31.

15.

Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.

Jiang C, Parrish NF, Wilen CB, Li H, Chen Y, Pavlicek JW, Berg A, Lu X, Song H, Tilton JC, Pfaff JM, Henning EA, Decker JM, Moody MA, Drinker MS, Schutte R, Freel S, Tomaras GD, Nedellec R, Mosier DE, Haynes BF, Shaw GM, Hahn BH, Doms RW, Gao F.

J Virol. 2011 Oct;85(20):10669-81. doi: 10.1128/JVI.05249-11. Epub 2011 Aug 10.

16.

Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.

Wilen CB, Parrish NF, Pfaff JM, Decker JM, Henning EA, Haim H, Petersen JE, Wojcechowskyj JA, Sodroski J, Haynes BF, Montefiori DC, Tilton JC, Shaw GM, Hahn BH, Doms RW.

J Virol. 2011 Sep;85(17):8514-27. doi: 10.1128/JVI.00736-11. Epub 2011 Jun 29.

17.

HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.

Pfaff JM, Wilen CB, Harrison JE, Demarest JF, Lee B, Doms RW, Tilton JC.

J Virol. 2010 Jul;84(13):6505-14. doi: 10.1128/JVI.00374-10. Epub 2010 Apr 21.

18.

The web browser as a unifying agent for radiology and the health care enterprise.

Garland HT, Cavanaugh BJ, Evans CS, Kreis A, Pfaff JM.

J Digit Imaging. 2000 May;13(2 Suppl 1):145-6.

19.

Mammographic changes after excisional breast biopsy for benign disease.

Brenner RJ, Pfaff JM.

AJR Am J Roentgenol. 1996 Oct;167(4):1047-52.

PMID:
8819410
20.
23.

Computer analysis of Doppler color flow mapping images for quantitative assessment of in vitro fluid jets.

Bolger AF, Eigler NL, Pfaff JM, Resser KJ, Maurer G.

J Am Coll Cardiol. 1988 Aug;12(2):450-7.

24.

Digital angiographic measurement of radiographic contrast material kinetics for estimation of myocardial perfusion.

Whiting JS, Drury JK, Pfaff JM, Chang BL, Eigler NL, Meerbaum S, Corday E, Nivatpumin T, Forrester JS, Swan HJ.

Circulation. 1986 Apr;73(4):789-98.

PMID:
3948375
25.

The role of digital angiography in the evaluation of coronary artery disease.

Eigler N, Pfaff JM, Whiting J, Nivatpumin T, Forrester JS.

Int J Cardiol. 1986 Jan;10(1):3-13. Review. No abstract available.

PMID:
3510988
26.

Digital quantification eliminates intraobserver and interobserver variability in the evaluation of coronary artery stenosis.

Vas R, Eigler N, Miyazono C, Pfaff JM, Resser KJ, Weiss M, Nivatpumin T, Whiting J, Forrester J.

Am J Cardiol. 1985 Nov 1;56(12):718-23.

PMID:
4061294
27.

Fibrinolytic therapy of St. Jude valve thrombosis under guidance of digital cinefluoroscopy.

Czer LS, Weiss M, Bateman TM, Pfaff JM, DeRobertis M, Eigler N, Vas R, Matloff JM, Gray RJ.

J Am Coll Cardiol. 1985 May;5(5):1244-9.

28.

On the utility of a simple model for the calculation of k-edge filtered x-ray spectra.

Barton J, Frank E, Pfaff JM.

Med Phys. 1982 May-Jun;9(3):425-8. No abstract available.

PMID:
7110072

Supplemental Content

Loading ...
Support Center